72 related articles for article (PubMed ID: 16150622)
1. Prodrug of proline analogue reduces hypoxic pulmonary hypertension in rats.
Simon PM; Pachence J; Belinka B; Poiani GJ; Lu SE; Tozzi CA; Riley DJ
Pulm Pharmacol Ther; 2006; 19(4):242-50. PubMed ID: 16150622
[TBL] [Abstract][Full Text] [Related]
2. Polymeric carrier of proline analogue with antifibrotic effect in pulmonary vascular remodeling.
Poiani GJ; Kemnitzer JE; Fox JD; Tozzi CA; Kohn J; Riley DJ
Am J Respir Crit Care Med; 1997 Apr; 155(4):1384-90. PubMed ID: 9105083
[TBL] [Abstract][Full Text] [Related]
3. Reduction of chronic hypoxic pulmonary hypertension in the rat by an inhibitor of collagen production.
Kerr JS; Ruppert CL; Tozzi CA; Neubauer JA; Frankel HM; Yu SY; Riley DJ
Am Rev Respir Dis; 1987 Feb; 135(2):300-6. PubMed ID: 3813190
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human relaxin reduces hypoxic pulmonary hypertension in the rat.
Tozzi CA; Poiani GJ; McHugh NA; Shakarjian MP; Grove BH; Samuel CS; Unemori EN; Riley DJ
Pulm Pharmacol Ther; 2005; 18(5):346-53. PubMed ID: 15939313
[TBL] [Abstract][Full Text] [Related]
5. An antifibrotic agent reduces blood pressure in established pulmonary hypertension in the rat.
Poiani GJ; Tozzi CA; Choe JK; Yohn SE; Riley DJ
J Appl Physiol (1985); 1990 Apr; 68(4):1542-7. PubMed ID: 2347793
[TBL] [Abstract][Full Text] [Related]
6. Polymer of proline analogue with sustained antifibrotic activity in lung fibrosis.
Greco MJ; Kemnitzer JE; Fox JD; Choe JK; Kohn J; Riley DJ; Poiani GJ
Am J Respir Crit Care Med; 1997 Apr; 155(4):1391-7. PubMed ID: 9105084
[TBL] [Abstract][Full Text] [Related]
7. Conjugates of cis-4-hydroxy-L-proline and poly(PEG-Lys), a water soluble poly(ether urethane): synthesis and evaluation of antifibrotic effects in vitro and in vivo.
Poiani GJ; Riley DJ; Fox JD; Kemnitzer JE; Gean KF; Kohn J
Bioconjug Chem; 1994; 5(6):621-30. PubMed ID: 7873665
[TBL] [Abstract][Full Text] [Related]
8. Exercise training improves lung gas exchange and attenuates acute hypoxic pulmonary hypertension but does not prevent pulmonary hypertension of prolonged hypoxia.
Favret F; Henderson KK; Allen J; Richalet JP; Gonzalez NC
J Appl Physiol (1985); 2006 Jan; 100(1):20-5. PubMed ID: 16179398
[TBL] [Abstract][Full Text] [Related]
9. [Effects of thromboxane A2 on chronic hypoxic pulmonary hypertension in the rat].
Saito M; Tatsumi K; Kasahara Y; Sugito K; Igari H; Tani T; Kuriyama T
Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Jan; 34(1):37-44. PubMed ID: 8717289
[TBL] [Abstract][Full Text] [Related]
10. Inhaled Rho kinase inhibitors are potent and selective vasodilators in rat pulmonary hypertension.
Nagaoka T; Fagan KA; Gebb SA; Morris KG; Suzuki T; Shimokawa H; McMurtry IF; Oka M
Am J Respir Crit Care Med; 2005 Mar; 171(5):494-9. PubMed ID: 15563635
[TBL] [Abstract][Full Text] [Related]
11. Liposome-entrapped antifibrotic agent prevents collagen accumulation in hypertensive pulmonary arteries of rats.
Poiani GJ; Wilson FJ; Fox JD; Sumka JM; Peng BW; Liao WC; Tozzi CA; Riley DJ
Circ Res; 1992 May; 70(5):912-22. PubMed ID: 1568301
[TBL] [Abstract][Full Text] [Related]
12. ZD1611, an orally active endothelin-A receptor antagonist, prevents chronic hypoxia-induced pulmonary hypertension in the rat.
Bialecki RA; Fisher CS; Abbott BM; Barthlow HG; Caccese RG; Stow RB; Rumsey J; Rumsey W
Pulm Pharmacol Ther; 1999; 12(5):303-12. PubMed ID: 10545286
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase type 5 as a target for the treatment of hypoxia-induced pulmonary hypertension.
Sebkhi A; Strange JW; Phillips SC; Wharton J; Wilkins MR
Circulation; 2003 Jul; 107(25):3230-5. PubMed ID: 12796132
[TBL] [Abstract][Full Text] [Related]
14. CPU0507, an endothelin receptor antagonist, improves rat hypoxic pulmonary artery hypertension and constriction in vivo and in vitro.
Yuan SH; Dai DZ; Guan L; Dai Y; Ji M
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1066-72. PubMed ID: 17042916
[TBL] [Abstract][Full Text] [Related]
15. BAY 41-2272, a direct activator of soluble guanylate cyclase, reduces right ventricular hypertrophy and prevents pulmonary vascular remodeling during chronic hypoxia in neonatal rats.
Deruelle P; Balasubramaniam V; Kunig AM; Seedorf GJ; Markham NE; Abman SH
Biol Neonate; 2006; 90(2):135-44. PubMed ID: 16582538
[TBL] [Abstract][Full Text] [Related]
16. Exogenous nitric oxide centrally enhances pulmonary reactivity in the normal and hypertensive rat.
Schwenke DO; Pearson JT; Tsuchimochi H; Mori H; Shirai M
Clin Exp Pharmacol Physiol; 2005 Nov; 32(11):952-9. PubMed ID: 16405452
[TBL] [Abstract][Full Text] [Related]
17. [The acute effect of tetrandrine pulmonary targeting microspheres on hypoxic pulmonary hypertension in rats].
Cheng D; Chen W; Lu B
Zhonghua Jie He He Hu Xi Za Zhi; 2000 May; 23(5):289-91. PubMed ID: 11778220
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of chronic hypoxic pulmonary hypertension in rats by cyclooxygenase products and by nitric oxide.
Russell P; Wright C; Kapeller K; Barer G; Howard P
Eur Respir J; 1993 Nov; 6(10):1501-6. PubMed ID: 7509294
[TBL] [Abstract][Full Text] [Related]
19. [Laboratory study on protective and therapeutic effects of pinacidil on pulmonary vascular remodeling in rats with hypoxia-induced pulmonary hypertension].
Zhong X; Liang G; He Z
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Dec; 23(12):727-9. PubMed ID: 11778477
[TBL] [Abstract][Full Text] [Related]
20. Amiloride analogs inhibit chronic hypoxic pulmonary hypertension.
Quinn DA; Du HK; Thompson BT; Hales CA
Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1263-8. PubMed ID: 9563749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
